Mini Review - Journal of Clinical Nephrology and Therapeutics (2023) Volume 7, Issue 5

Uric Acid-Lowering Medications: A Path to Gout Relief and Kidney Health

Elizabeth Goswami ^*

Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Scotland, Albany

*Corresponding Author:

Elizabeth Goswami
Department of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Scotland, Albany
E-mail: Elizabeth@edu

Received:Editor assigned: 03-Oct -2023, PreQC No. AACNT-23-115824 (PQ); Reviewed:17-Oct-2023, QC No. AACNT-23-115824; Revised:22-Oct-2023, Manuscript No. AACNT-23-115824(R); Published: 30-Oct -2023, DOI:10.35841/ aacnt-7.5.167

Citation: Goswami E. Uric Acid-Lowering medications: A path to gout relief and kidney health. J Cogn Neurosci 2023;7(5):167

Introduction

Gout, a painful form of arthritis, has been known as the "disease of kings" due to its historical association with rich foods and excesses. Today, gout affects millions of people, regardless of their status, and is primarily caused by high levels of uric acid in the bloodstream. Uric acid-lowering medications are a vital component in the treatment of gout and related conditions. In this article, we will delve into the world of these medications, their types, mechanisms of action, and the significant impact they have on both gout relief and kidney health. Uric acid-lowering medications are a class of drugs used to treat hyperuricemia, a condition characterized by abnormally high levels of uric acid in the bloodstream. Hyperuricemia can lead to the formation of urate crystals in the joints and tissues, resulting in a painful condition known as gout. Additionally, high uric acid levels can contribute to the development of kidney stones and kidney disease. Uric acid-lowering medications aim to reduce uric acid levels and prevent the associated health complications [1].

Home-Based: PD can be performed at home, providing patients with greater independence and flexibility in their treatment schedule. It offers continuous and gentle waste removal, which can lead to more stable blood pressure and fluid balance. Fewer Visits to Dialysis Centers: Patients on PD generally have fewer visits to dialysis centers, reducing the need for travel [2].

The peritoneal dialysis process

Peritoneal dialysis relies on the peritoneal membrane, a thin, natural lining that surrounds the abdominal organs. In this therapy, a sterile dialysis solution is introduced into the peritoneal cavity through a catheter, typically placed in the lower abdomen. This solution contains a carefully balanced mixture of electrolytes and glucose, which draws waste products and excess fluids from the bloodstream into the peritoneal cavity. After a dwell time, during which the solution remains in the abdomen, it is drained out, carrying the accumulated waste and fluids with it. This process, consisting of inflow, dwell, and outflow phases, is known as an exchange, and it can be repeated multiple times a day depending on the patient's prescribed regimen [3].

Advantages of peritoneal dialysis

Peritoneal dialysis offers several advantages over traditional hemodialysis. Firstly, it can be performed at home, allowing patients to maintain a more flexible schedule and reducing the need for frequent visits to a dialysis center. This independence can improve the patient's overall quality of life, as they can continue to work, travel, and engage in daily activities with more ease. Moreover, because peritoneal dialysis is continuous and gentler on the body, it can lead to more stable blood pressure and fluid balance, reducing the risk of complications like hypotension and muscle cramps that are often associated with hemodialysis. Additionally, it provides a more gradual and continuous removal of waste products, potentially leading to improved clearance and reduced dietary restrictions for patients. There are two main modalities of peritoneal dialysis: Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). CAPD involves manual exchanges performed by the patient or caregiver several times a day. It offers flexibility but requires more active patient involvement. APD, on the other hand, uses a machine called a cycler to perform exchanges during the night while the patient sleeps, offering convenience and allowing for a more regular daily routine. The choice between CAPD and APD depends on individual patient preferences, lifestyle, and medical considerations, and healthcare providers work closely with patients to determine the most suitable modality [4].

Impact on quality of life

Peritoneal dialysis not only offers clinical benefits but also has a positive impact on the quality of life for ESRD patients. The ability to manage treatment at home fosters a sense of control and autonomy, reducing the emotional burden often associated with chronic medical conditions. Patients on peritoneal dialysis report improved overall well-being, greater satisfaction with their treatment, and a reduced sense of dependency on healthcare facilities. In conclusion, peritoneal dialysis is a valuable renal replacement therapy that has transformed the lives of countless individuals living with ESRD. Its home-based nature, gentle continuous process, and flexibility make it a compelling option for those seeking to maintain a fulfilling life while managing their condition. With ongoing advancements in technology and patient care, peritoneal dialysis continues to offer hope and improved outcomes for ESRD patients worldwide [5].

References

1. Fried JL, Maxey HL, Battani K, et al. Preparing the future dental hygiene workforce: knowledge, skills, and reform. J Dent Educ. 2017;81(9):eS45-52.

Indexed at, Google Scholar, Cross Ref

2. Yazdanian M, Rostamzadeh P, Rahbar M, et al. The potential application of green-synthesized metal nanoparticles in dentistry: A comprehensive review. Bioinorganic Chemistry and Applications. 2022;2022.

Indexed at, Google Scholar, Cross Ref

3. Sharan J, Singh S, Lale SV, et al. Applications of nanomaterials in dental science: A review. J Nanosci 2017;17(4):2235-55.

Indexed at, Google Scholar, Cross Ref

4. Abou Neel EA, Bozec L, Perez RA, et al. Nanotechnology in dentistry: prevention, diagnosis, and therapy. int j nanomed. 2015:6371-94.

Indexed at, Google Scholar, Cross Ref

5. Noronha VT, Paula AJ, Durán G, et al. Silver nanoparticles in dentistry. Dental Materials. 2017;33(10):1110-26.

Google Scholar